(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TELAVANT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TELAVANT

ST13

US500000098024960

Class

5, 42, 44

Filing

98024960

Registration

7454236

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

04/11/2026

Trademark type

Word

Nice classes

5, 42, 44

Filing date

06/02/2023

Registration date

07/23/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/23/2024

Last transaction

04/11/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

03

Owner location

SOUTH SAN FRANCISCO, CA, US

Examiner

MCCARTHY, JOSEPH PATRICK

Law office

N90

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

TELAVANT HOLDINGS, INC.
Roivant Sciences GmbH

Representatives

Gregory Zinkl

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for human use to treat Colitis ulcerosa and Morbus Crohn; biologic preparations for medical and therapeutic purposes to treat Colitis ulcerosa and Morbus Crohn; pharmaceutical preparations to treat gastrointestinal diseases and disorders and immunological diseases and disorders; biologic preparations to treat gastrointestinal diseases and disorders and immunological diseases and disorders

Class 42

Scientific and technological services namelyscientific research and design in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical and biomedical research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals and biomedicine; medical and scientific researchconducting clinical trials for others

Class 44

Providing health and medical information; providing information relating to the diagnosticprophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseasesdisorders and conditions

Publications

History of USPTO decisions and trademark events.

33 publications found

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

04/09/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/09/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/09/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/09/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/09/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/09/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/07/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/07/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/07/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/07/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/07/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/23/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

07/23/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/07/2024

PUBO

PUBLISHED FOR OPPOSITION

05/07/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/17/2024

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

04/03/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/01/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/25/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/25/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/25/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/01/2024

GNRT

NON-FINAL ACTION E-MAILED

03/01/2024

CNRT

NON-FINAL ACTION WRITTEN

03/01/2024

DOCK

ASSIGNED TO EXAMINER

02/26/2024

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

11/08/2023

ALIE

ASSIGNED TO LIE

11/08/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/06/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/08/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/08/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/08/2023

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

06/06/2023

NWAP

NEW APPLICATION ENTERED

06/06/2023

Continuous trademark protection

Get notified about every new filing that threatens TELAVANT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.